Federal Supply Schedule V797D70251
Award Date 9/30/17
Last Date to Order 5/31/24
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs, to Luye Pharma USA LTD, a foreign-owned for-profit organization. The $25,000 contract is for an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The period of performance runs from the award date of April 3, 2025 through September 30, 2025. No set-asides were used, and...
- The Federal Supply Schedule contract ID 36F79724D0132 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to the prime contractor Eisai Inc. The contract is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. The contract is a multiple award, has no set-aside, and has a total ceiling value of $361,746,990.00. The period of performance extends from the award date of June 1, 2024 to the ultimate completion date of May...
- The contract is a Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Eyevance Pharmaceuticals LLC, a foreign-owned for-profit manufacturer. The FSS contract is under Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, with a potential value of $450,000 and a period of performance through December 14, 2024. The contract aims to procure a range of pharmaceutical and drug products from the vendor. As an FSS...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Lundbeck LLC, a global pharmaceutical company, a Federal Supply Schedule (FSS) contract and Blanket Purchase Agreement (BPA) to provide specialized drugs and therapies to treat neurological disorders among veterans. The FSS contract, valued at up to $124 million over 7 years, allows VA Networks and Medical Centers to issue delivery orders to Lundbeck for pharmaceuticals such as Sabril, Xenazine, and Northera...
- This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Lupin Pharmaceuticals, Inc., provides pharmaceuticals to the U.S. federal government. The $45,000,000.00 contract has an ultimate completion date of March 14, 2022 and was originally awarded on March 15, 2012. The contract is categorized under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, which is a multiple award vehicle that allows federal agencies to purchase a wide...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Esperion Therapeutics, Inc. on October 15, 2020. The contract is classified under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and has a ceiling value of $225,000.00. The period of performance extends through April 14, 2026. The contract provides for the delivery of pharmaceutical and hematology-related products to the Department of Veterans...
- This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to EMD Serono Inc. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and has a ceiling value of $271,515,660.00. The period of performance runs from the award date of April 15, 2018 through April 14, 2025. The contract is intended to procure a wide range of pharmaceutical and hematology-related products for the Department of...
- This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Mitsubishi Tanabe Pharma America, Inc., is for the provision of drugs, pharmaceuticals, and hematology-related products. The $532,000,000 multiple-award contract has a period of performance through December 31, 2028. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and allows the VA and other authorized federal agencies to procure a wide range of pharmaceutical...
- The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract, V797D70240, to Helsinn Therapeutics (U.S.), Inc. (doing business as Helsinn Therapeutics US Inc.), a for-profit manufacturer of pharmaceutical products. The FSS contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, has a ceiling value of $3,281,482.80 and a period of performance through February 2025. Under this FSS contract, Helsinn Therapeutics has received several delivery order...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs to Lupin Pharmaceuticals, Inc. on March 15, 2022. The contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, has a ceiling value of $225,000.00 and a period of performance through March 14, 2027. The contract is for the provision of pharmaceutical and hematology-related products under the 65 I B product code. This includes a deletion of product code 42-2A, indicating that a product has been...
Name | Description | Awardee | Potential Value | AwardDate | LastDateToOrder | Updated At |
|---|---|---|---|---|---|---|
V797D70251-36E79718A0004 | Eisai Inc. | $17.3m | 10/19/17 | 1/14/19 | 1/14/19 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36E79718A0004-36C24719K0036 | Eisai Inc. | $20.7k | 10/10/18 | 11/9/18 | 10/10/18 | |
Delivery Order V797D70251-36C25919F0147 | Eisai Inc. | $10.9k | 1/9/19 | 1/31/19 | 1/9/19 | |
Delivery Order V797D70251-36C24918N0223 | Eisai Inc. | $9.4k | 10/19/17 | 10/24/17 | 10/19/17 | |
Delivery Order V797D70251-36C25918K3911 | Eisai Inc. | $41.5k | 4/8/18 | 12/1/21 | 12/1/21 | |
Delivery Order V797D70251-36C26119F0076 | Eisai Inc. | $11.1k | 10/25/18 | 10/26/18 | 10/25/18 |